[Darier-Ferrand dermatofibrosarcoma. Apropos of a case with frontal involvement].

L Richard(Université de Rouen Normandie), D Bemelmans, A Ouadah, D Cantaloube, P. Combemale(Centre Léon Bérard)

PubMed

January 1, 1994

Cited by 0

Related Papers

Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase 2 trial

|The Lancet Oncology|2015|432

Prevalence and association of perceived stress, substance use and behavioral addictions: a cross-sectional study among university students in France, 2009–2011

|BMC Public Health|2013|309

Long‐term efficacy and safety of sonidegib in patients with advanced basal cell carcinoma: 42‐month analysis of the phase II randomized, double‐blind BOLT study

|British Journal of Dermatology|2019|197

Translocation, t(17;22)(q22;q13), in dermatofibrosarcoma protuberans: a new tumor-associated chromosome rearrangement

|Cytogenetics and Cell Genetics|2008|194

Long‐term efficacy and safety of sonidegib in patients with locally advanced and metastatic basal cell carcinoma: 30‐month analysis of the randomized phase 2 BOLT study

|Journal of the European Academy of Dermatology and Venereology|2017|192